Leidos Holdings Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) increased by 100.0% to $126.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 137.7%, from $53.00M to $126.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher values indicate a larger near-term drag on reported earnings due to previous acquisition activity.
This represents the projected non-cash expense related to the amortization of finite-lived intangible assets for the upc...
Companies with high M&A activity in the medical device space typically report significant annual amortization expenses.
finite_lived_intangible_assets_amortization_year_1| Q1 '21 | Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $110.00M | $125.00M | $136.00M | $96.00M | $95.00M | $94.00M | $72.00M | $72.00M | $66.00M | $62.00M | $62.00M | $62.00M | $53.00M | $59.00M | $63.00M | $126.00M |
| QoQ Change | — | +13.6% | +8.8% | -29.4% | -1.0% | -1.1% | -23.4% | +0.0% | -8.3% | -6.1% | +0.0% | +0.0% | -14.5% | +11.3% | +6.8% | +100.0% |
| YoY Change | — | — | — | -12.7% | -24.0% | -30.9% | -25.0% | -24.2% | -29.8% | -13.9% | -13.9% | -6.1% | -14.5% | -4.8% | +1.6% | +137.7% |